Brief Information of the Cell Line and Protein
Cell Line ID: CL000058 , T-REx-293
Synonyms
T-REx 293
T-REx293
TRex-293
TREx293
T-REx-HEK293
T-REx HEK 293
HEK293-T-REx
HEK293-Trex
Category Transformed cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_D585
Protein ID: PT00911 , Melanocyte-stimulating hormone receptor
Gene Name MC1R
Organism Homo sapiens, Human
Protein Classification Membrane receptor
Uniprot ID Q01726
Table of Molecular Bioactivities Related to the Cell Line and Protein
Cell Line ID: CL000058  Protein ID: PT00911
 
Compound ID Compound Name Compound Formula
CP0091326
(3S,6S,9R,12S,15S,23S)-15-((S)-2-acetylamino-hexanoylamino)-9-benzyl-6-(3-guanidino-propyl)-12-(3H-imidazol-4-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18hexaaza-cyclotricosane-23-carboxylic acid amide
   Show/Hide
C50H69N15O9
 1
1
EC50 < 0.05012 nM
   TI
   LI
   LO
   TS
CP0912423
1-[3-[(1R,4S,7S,13S,16S,19R,22S,25S,28R,31S,34S,37S,40R,43S)-19,40-dibenzyl-4-[(2S)-butan-2-yl]-16,31-bis(3-carbamimidamidopropyl)-25-[(1R)-1-hydroxyethyl]-22,43-bis(1H-imidazol-4-ylmethyl)-13,34-bis(1H-indol-3-ylmethyl)-17,35,38-trimethyl-3,6,12,15,18,21,24,27,30,33,36,39,42,45-tetradecaoxo-47,48-dithia-2,5,11,14,17,20,23,26,29,32,35,38,41,44-tetradecazatricyclo[26.17.4.07,11]nonatetracontan-37-yl]propyl]guanidine
   Show/Hide
C94H127N29O15S2
 1
1
EC50 < 0.05012 nM
   TI
   LI
   LO
   TS
CP0955092
1-[3-[(1R,4S,7S,13S,16S,19R,22S,25S,28R,31S,34S,37S,40R,43S)-19,40-dibenzyl-4-[(2S)-butan-2-yl]-16-(3-carbamimidamidopropyl)-25-[(1R)-1-hydroxyethyl]-22,43-bis(1H-imidazol-4-ylmethyl)-13,34-bis(1H-indol-3-ylmethyl)-17,31-dimethyl-3,6,12,15,18,21,24,27,30,33,36,39,42,45-tetradecaoxo-47,48-dithia-2,5,11,14,17,20,23,26,29,32,35,38,41,44-tetradecazatricyclo[26.17.4.07,11]nonatetracontan-37-yl]propyl]guanidine
   Show/Hide
C89H116N26O15S2
 1
1
EC50 = 0.05623 nM
   TI
   LI
   LO
   TS
CP0912430
2-[(1R,4S,7S,13S,16S,19R,22S,25S,28R,31S,34S,37S,40R,43S)-19,40-dibenzyl-4-[(2S)-butan-2-yl]-16,37-bis(3-carbamimidamidopropyl)-31-[(4-hydroxyphenyl)methyl]-22,43-bis(1H-imidazol-4-ylmethyl)-13,34-bis(1H-indol-3-ylmethyl)-17,35,38-trimethyl-3,6,12,15,18,21,24,27,30,33,36,39,42,45-tetradecaoxo-47,48-dithia-2,5,11,14,17,20,23,26,29,32,35,38,41,44-tetradecazatricyclo[26.17.4.07,11]nonatetracontan-25-yl]acetic acid
   Show/Hide
C97H122N26O17S2
 1
1
EC50 = 0.06457 nM
   TI
   LI
   LO
   TS
CP0455645
BREMELANOTIDE
   Show/Hide
C50H68N14O10
 1
1
EC50 = 0.07762 nM
   TI
   LI
   LO
   TS
CP0967558
3-[(1R,4S,7S,13S,16S,19R,22S,25S,28R,31S,34S,37S,40R,43S)-19,40-dibenzyl-4-[(2S)-butan-2-yl]-16,31,37-tris(3-carbamimidamidopropyl)-22,43-bis(1H-imidazol-4-ylmethyl)-13,34-bis(1H-indol-3-ylmethyl)-17,35,38-trimethyl-3,6,12,15,18,21,24,27,30,33,36,39,42,45-tetradecaoxo-47,48-dithia-2,5,11,14,17,20,23,26,29,32,35,38,41,44-tetradecazatricyclo[26.17.4.07,11]nonatetracontan-25-yl]propanoic acid
   Show/Hide
C95H127N29O16S2
 1
1
EC50 = 0.08318 nM
   TI
   LI
   LO
   TS
CP0955843
1-[3-[(1R,4S,7S,10S,13S,16R,19S,22S,25R,28S,31S,34S,37R,40S)-16,37-dibenzyl-4-[(2S)-butan-2-yl]-13-(3-carbamimidamidopropyl)-22-[(1R)-1-hydroxyethyl]-19,40-bis(1H-imidazol-4-ylmethyl)-10,31-bis(1H-indol-3-ylmethyl)-7,14,28-trimethyl-3,6,9,12,15,18,21,24,27,30,33,36,39,42-tetradecaoxo-44,45-dithia-2,5,8,11,14,17,20,23,26,29,32,35,38,41-tetradecazabicyclo[23.17.4]hexatetracontan-34-yl]propyl]guanidine
   Show/Hide
C87H114N26O15S2
 1
1
EC50 = 0.0912 nM
   TI
   LI
   LO
   TS
CP0966185
2-[(1R,4S,7S,13S,16S,19R,22S,25S,28R,31S,34S,37S,40R,43S)-19,40-dibenzyl-4-[(2S)-butan-2-yl]-16,31,37-tris(3-carbamimidamidopropyl)-22,43-bis(1H-imidazol-4-ylmethyl)-13,34-bis(1H-indol-3-ylmethyl)-17,35,38-trimethyl-3,6,12,15,18,21,24,27,30,33,36,39,42,45-tetradecaoxo-47,48-dithia-2,5,11,14,17,20,23,26,29,32,35,38,41,44-tetradecazatricyclo[26.17.4.07,11]nonatetracontan-25-yl]acetic acid
   Show/Hide
C94H125N29O16S2
 1
1
EC50 = 0.1096 nM
   TI
   LI
   LO
   TS
CP0912431
1-[3-[(1R,4S,7S,13S,16S,19R,22S,25S,28R,31S,34S,37S,40R,43S)-19,40-dibenzyl-4-[(2S)-butan-2-yl]-16,31-bis(3-carbamimidamidopropyl)-25-[(1R)-1-hydroxyethyl]-22,43-bis(1H-imidazol-4-ylmethyl)-13,34-bis(1H-indol-3-ylmethyl)-17-methyl-3,6,12,15,18,21,24,27,30,33,36,39,42,45-tetradecaoxo-47,48-dithia-2,5,11,14,17,20,23,26,29,32,35,38,41,44-tetradecazatricyclo[26.17.4.07,11]nonatetracontan-37-yl]propyl]guanidine
   Show/Hide
C92H123N29O15S2
 1
1
EC50 = 0.1349 nM
   TI
   LI
   LO
   TS
CP0954206
1-[3-[(1R,4S,7S,13S,16S,19R,22S,25S,28R,31S,34S,37S,40R,43S)-19,40-dibenzyl-4-[(2S)-butan-2-yl]-16,31-bis(3-carbamimidamidopropyl)-25-[(1R)-1-hydroxyethyl]-22,43-bis(1H-imidazol-4-ylmethyl)-13,34-bis(1H-indol-3-ylmethyl)-3,6,12,15,18,21,24,27,30,33,36,39,42,45-tetradecaoxo-47,48-dithia-2,5,11,14,17,20,23,26,29,32,35,38,41,44-tetradecazatricyclo[26.17.4.07,11]nonatetracontan-37-yl]propyl]guanidine
   Show/Hide
C91H121N29O15S2
 1
1
EC50 = 0.138 nM
   TI
   LI
   LO
   TS
CP0950967
3-[(1R,4S,7S,13S,16S,19R,22S,25S,28R,31S,34S,37S,40R,43S)-19,40-dibenzyl-4-[(2S)-butan-2-yl]-31,37-bis(3-carbamimidamidopropyl)-25-[(1R)-1-hydroxyethyl]-22,43-bis(1H-imidazol-4-ylmethyl)-13,34-bis(1H-indol-3-ylmethyl)-35,38-dimethyl-3,6,12,15,18,21,24,27,30,33,36,39,42,45-tetradecaoxo-47,48-dithia-2,5,11,14,17,20,23,26,29,32,35,38,41,44-tetradecazatricyclo[26.17.4.07,11]nonatetracontan-16-yl]propanoic acid
   Show/Hide
C92H120N26O17S2
 1
1
EC50 = 0.1413 nM
   TI
   LI
   LO
   TS
CP0944140
SETMELANOTIDE
   Show/Hide
C49H68N18O9S2
 1
1
EC50 = 0.1585 nM
   TI
   LI
   LO
   TS
CP0954207
1-[3-[(1R,4S,7S,13S,16S,19R,22S,25S,28R,31S,34S,37S,40R,43S)-19,40-dibenzyl-4-[(2S)-butan-2-yl]-16,31-bis(3-carbamimidamidopropyl)-25-[(1R)-1-hydroxyethyl]-22,43-bis(1H-imidazol-4-ylmethyl)-13-(1H-indol-3-ylmethyl)-17,34-dimethyl-3,6,12,15,18,21,24,27,30,33,36,39,42,45-tetradecaoxo-47,48-dithia-2,5,11,14,17,20,23,26,29,32,35,38,41,44-tetradecazatricyclo[26.17.4.07,11]nonatetracontan-37-yl]propyl]guanidine
   Show/Hide
C84H118N28O15S2
 1
1
EC50 = 0.4266 nM
   TI
   LI
   LO
   TS
CP0952333
1-[3-[(1R,4S,7S,13S,16S,19R,22S,25S,28R,31S,34S,37S,40R,43S)-4,19,40-tribenzyl-16-(3-carbamimidamidopropyl)-25-[(1R)-1-hydroxyethyl]-22,43-bis(1H-imidazol-4-ylmethyl)-13,34-bis(1H-indol-3-ylmethyl)-17,31-dimethyl-3,6,12,15,18,21,24,27,30,33,36,39,42,45-tetradecaoxo-47,48-dithia-2,5,11,14,17,20,23,26,29,32,35,38,41,44-tetradecazatricyclo[26.17.4.07,11]nonatetracontan-37-yl]propyl]guanidine
   Show/Hide
C92H114N26O15S2
 1
1
EC50 = 0.6918 nM
   TI
   LI
   LO
   TS
CP0912429
1-[3-[(1R,4S,7S,13S,19S,22S,25S,28S,31R,34S,37S,40S,43R,46S)-43-benzyl-4,19-bis[(2S)-butan-2-yl]-34-(3-carbamimidamidopropyl)-28-[(1R)-1-hydroxyethyl]-22-(hydroxymethyl)-46-(1H-imidazol-4-ylmethyl)-37-(1H-indol-3-ylmethyl)-25,38,41-trimethyl-3,6,12,18,21,24,27,30,33,36,39,42,45,48-tetradecaoxo-50,51-dithia-2,5,11,17,20,23,26,29,32,35,38,41,44,47-tetradecazatetracyclo[29.17.4.07,11.013,17]dopentacontan-40-yl]propyl]guanidine
   Show/Hide
C78H115N23O16S2
 1
1
EC50 = 0.7586 nM
   TI
   LI
   LO
   TS
CP0955031
1-[3-[(1R,4S,7S,13S,16S,19R,22S,25S,28R,31S,34S,37S,40S,43S)-19-benzyl-4-[(2S)-butan-2-yl]-16,31-bis(3-carbamimidamidopropyl)-25-[(1R)-1-hydroxyethyl]-22,43-bis(1H-imidazol-4-ylmethyl)-13,34-bis(1H-indol-3-ylmethyl)-17,40-dimethyl-3,6,12,15,18,21,24,27,30,33,36,39,42,45-tetradecaoxo-47,48-dithia-2,5,11,14,17,20,23,26,29,32,35,38,41,44-tetradecazatricyclo[26.17.4.07,11]nonatetracontan-37-yl]propyl]guanidine
   Show/Hide
C86H119N29O15S2
 1
1
EC50 = 0.7943 nM
   TI
   LI
   LO
   TS
CP0941169
2-[(1R,4S,7R,10S,13S,16R,19S,25R,28S,31S,34S,37R,40S)-16,37-dibenzyl-4,13,28,34-tetrakis(3-carbamimidamidopropyl)-19,40-bis(1H-imidazol-4-ylmethyl)-10,31-bis(1H-indol-3-ylmethyl)-14,32,35-trimethyl-3,6,9,12,15,18,21,24,27,30,33,36,39,42-tetradecaoxo-44,45-dithia-2,5,8,11,14,17,20,23,26,29,32,35,38,41-tetradecazabicyclo[23.17.4]hexatetracontan-7-yl]acetic acid
   Show/Hide
C91H122N32O16S2
 1
1
EC50 = 0.8128 nM
   TI
   LI
   LO
   TS
CP0964820
1-[3-[(1R,4S,7S,13S,16S,19R,22S,25S,28R,31S,34S,37S,40R,43S)-37-(4-aminobutyl)-19,40-dibenzyl-4-[(2S)-butan-2-yl]-25-[(1R)-1-hydroxyethyl]-22,43-bis(1H-imidazol-4-ylmethyl)-13,34-bis(1H-indol-3-ylmethyl)-17,31-dimethyl-3,6,12,15,18,21,24,27,30,33,36,39,42,45-tetradecaoxo-47,48-dithia-2,5,11,14,17,20,23,26,29,32,35,38,41,44-tetradecazatricyclo[26.17.4.07,11]nonatetracontan-16-yl]propyl]guanidine
   Show/Hide
C89H116N24O15S2
 1
1
EC50 = 0.8318 nM
   TI
   LI
   LO
   TS
CP0912428
1-[3-[(1R,4S,7S,13S,16S,19R,22S,25S,28R,31S,34S,37S,40R,43S)-19,40-dibenzyl-16-(3-carbamimidamidopropyl)-25-[(1R)-1-hydroxyethyl]-22,43-bis(1H-imidazol-4-ylmethyl)-13,34-bis(1H-indol-3-ylmethyl)-4,17,31-trimethyl-3,6,12,15,18,21,24,27,30,33,36,39,42,45-tetradecaoxo-47,48-dithia-2,5,11,14,17,20,23,26,29,32,35,38,41,44-tetradecazatricyclo[26.17.4.07,11]nonatetracontan-37-yl]propyl]guanidine
   Show/Hide
C86H110N26O15S2
 1
1
EC50 = 1.072 nM
   TI
   LI
   LO
   TS
CP0954450
1-[3-[(1R,7S,13S,16R,19S,22S,28S,31S,34R,37S,40R,43S,46S,49S)-40-benzyl-31-[(2S)-butan-2-yl]-19-(3-carbamimidamidopropyl)-37-(1H-imidazol-4-ylmethyl)-22,46-bis(1H-indol-3-ylmethyl)-18,49-dimethyl-16-(naphthalen-2-ylmethyl)-2,8,14,17,20,23,29,32,35,38,41,44,47,50-tetradecaoxo-53,54-dithia-3,9,15,18,21,24,30,33,36,39,42,45,48,51-tetradecazapentacyclo[32.17.4.03,7.09,13.024,28]pentapentacontan-43-yl]propyl]guanidine
   Show/Hide
C93H118N24O14S2
 1
1
EC50 = 1.318 nM
   TI
   LI
   LO
   TS
CP0954452
1-[3-[(1R,4S,10S,13R,16S,19S,25S,28S,31R,34S,37R,40S,43S,46S)-37-benzyl-28-[(2S)-butan-2-yl]-16-(3-carbamimidamidopropyl)-34-(1H-imidazol-4-ylmethyl)-4,19,43-tris(1H-indol-3-ylmethyl)-15,46-dimethyl-13-(naphthalen-2-ylmethyl)-2,5,11,14,17,20,26,29,32,35,38,41,44,47-tetradecaoxo-50,51-dithia-3,6,12,15,18,21,27,30,33,36,39,42,45,48-tetradecazatetracyclo[29.17.4.06,10.021,25]dopentacontan-40-yl]propyl]guanidine
   Show/Hide
C99H121N25O14S2
 1
1
EC50 = 1.549 nM
   TI
   LI
   LO
   TS
CP0953230
1-[3-[(1R,4S,7S,13S,16S,19R,22S,25S,28R,31S,34S,37S,40R,43S)-19,40-dibenzyl-4-[(2S)-butan-2-yl]-16-(3-carbamimidamidopropyl)-25-[(1R)-1-hydroxyethyl]-22,43-bis(1H-imidazol-4-ylmethyl)-13,34-bis(1H-indol-3-ylmethyl)-17,37-dimethyl-3,6,12,15,18,21,24,27,30,33,36,39,42,45-tetradecaoxo-47,48-dithia-2,5,11,14,17,20,23,26,29,32,35,38,41,44-tetradecazatricyclo[26.17.4.07,11]nonatetracontan-31-yl]propyl]guanidine
   Show/Hide
C89H116N26O15S2
 1
1
EC50 = 2.239 nM
   TI
   LI
   LO
   TS
CP0955030
1-[3-[(1R,4S,7S,13S,16S,19R,22S,25S,28R,31S,34S,37S,40R,43S)-19,40-dibenzyl-4-[(2S)-butan-2-yl]-16,31-bis(3-carbamimidamidopropyl)-25-[(1R)-1-hydroxyethyl]-22-(1H-imidazol-4-ylmethyl)-13,34-bis(1H-indol-3-ylmethyl)-17,43-dimethyl-3,6,12,15,18,21,24,27,30,33,36,39,42,45-tetradecaoxo-47,48-dithia-2,5,11,14,17,20,23,26,29,32,35,38,41,44-tetradecazatricyclo[26.17.4.07,11]nonatetracontan-37-yl]propyl]guanidine
   Show/Hide
C89H121N27O15S2
 1
1
EC50 = 3.631 nM
   TI
   LI
   LO
   TS
CP0964819
3-[(1R,4S,7S,13S,16S,19R,22S,25S,28R,31S,34S,37S,40R,43S)-19,40-dibenzyl-4-[(2S)-butan-2-yl]-16,31-bis(3-carbamimidamidopropyl)-25-[(1R)-1-hydroxyethyl]-22,43-bis(1H-imidazol-4-ylmethyl)-13,34-bis(1H-indol-3-ylmethyl)-17-methyl-3,6,12,15,18,21,24,27,30,33,36,39,42,45-tetradecaoxo-47,48-dithia-2,5,11,14,17,20,23,26,29,32,35,38,41,44-tetradecazatricyclo[26.17.4.07,11]nonatetracontan-37-yl]propanoic acid
   Show/Hide
C91H118N26O17S2
 1
1
EC50 = 3.631 nM
   TI
   LI
   LO
   TS
CP0950966
(4R,7S,10S,13S,16S,19S,22R)-19-((1H-imidazol-4-yl)methyl)-10-((1H-indol-3-yl)methyl)-22-acetamido-16-benzyl-7,13-bis(3-guanidinopropyl)-11,14-dimethyl-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexaazacyclotricosane-4-carboxamide
   Show/Hide
C48H67N17O8S2
 1
1
EC50 = 5.495 nM
   TI
   LI
   LO
   TS
CP0953427
(3S,6S,9R,12S,15S,18R,23R,26S,29S)-18-acetamido-9-benzyl-6-(3-guanidinopropyl)-15-[(1R)-1-hydroxyethyl]-12-(1H-imidazol-4-ylmethyl)-3-(1H-indol-3-ylmethyl)-7-methyl-26-[(1S)-1-methylpropyl]-2,5,8,11,14,17,25,28-octaoxo-20,21-dithia-1,4,7,10,13,16,24,27-octazabicyclo[27.3.0]dotriacontane-23-carboxamide
   Show/Hide
C56H78N16O11S2
 1
1
EC50 = 8.71 nM
   TI
   LI
   LO
   TS
CP0432642
2-[(1R,4S,7S,13S,16S,19R,22S,25S,28R,31S,37S,40S,46S)-19,46-dibenzyl-4-[(2S)-butan-2-yl]-16,31-bis(3-carbamimidamidopropyl)-25-[(1R)-1-hydroxyethyl]-22-(1H-imidazol-5-ylmethyl)-13-(1H-indol-3-ylmethyl)-14-methyl-3,6,12,15,18,21,24,27,30,33,36,39,45,48-tetradecaoxo-50,51-dithia-2,5,11,14,17,20,23,26,29,32,35,38,44,47-tetradecazatetracyclo[26.20.4.07,11.040,44]dopentacontan-37-yl]acetic acid
   Show/Hide
C80H109N23O17S2
 1
1
EC50 = 64.57 nM
   TI
   LI
   LO
   TS
CP0955805
1-[3-[(1R,4S,7S,13S,16S,19R,22S,25S,28R,31S,34S,37S,40R,43S)-19,40-dibenzyl-4-[(2S)-butan-2-yl]-16-(3-carbamimidamidopropyl)-25-[(1R)-1-hydroxyethyl]-22,43-bis(1H-imidazol-4-ylmethyl)-13-(1H-indol-3-ylmethyl)-17,31-dimethyl-34-(naphthalen-2-ylmethyl)-3,6,12,15,18,21,24,27,30,33,36,39,42,45-tetradecaoxo-47,48-dithia-2,5,11,14,17,20,23,26,29,32,35,38,41,44-tetradecazatricyclo[26.17.4.07,11]nonatetracontan-37-yl]propyl]guanidine
   Show/Hide
C91H117N25O15S2
 1
1
EC50 > 0.05012 nM
   TI
   LI
   LO
   TS